| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sio Gene Therapies Inc. | Interim CEO, CFO, Director | Restricted Stock Units | 546,500 | 08 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000163605022000020-nassif-david-w-2022-02-08 | Sio Gene Therapies Inc. | 08 Feb 2022 | 1 | $0 | 4 | Interim CEO, CFO, Director | 10 Feb 2022, 16:05 |
| /report/000163605021000099-nassif-david-w-2021-12-08 | Sio Gene Therapies Inc. | 08 Dec 2021 | 3 | -$8,937 | 4 | Chief Financial Officer | 09 Dec 2021, 17:31 |